Your browser doesn't support javascript.
loading
Tobacco smoking and diabetes. A comparative survey among diabetologists and smoking cessation specialists.
Berlin, Ivan; Durlach, Vincent; Thomas, Daniel; Vergès, Bruno; Le Faou, Anne-Laurence.
Affiliation
  • Berlin I; Département de pharmacologie médicale, Hôpital Pitié-Salpêtrière-Sorbonne Université, Paris, France. Electronic address: ivan.berlin@aphp.fr.
  • Durlach V; Département Cardio-Thoracique, Université Champagne-Ardenne, UMR CNRS 7369 MEDy, Hôpital Universitaire de Reims, Reims, France.
  • Thomas D; Institut de cardiologie, Hôpital Pitié-Salpêtrière-Sorbonne Université, Paris, France.
  • Vergès B; Département d'endocrinologie, diabétologie et maladies métaboliques, Centre Hospitalier de Dijon, INSERM LNC-UMR1231, Université de Bourgogne, Dijon, France.
  • Le Faou AL; Centre ambulatoire d'addictologie, Hôpital Européen George Pompidou, AP-HP - Centre-Université de Paris Cité, Paris, France.
Prim Care Diabetes ; 18(2): 241-245, 2024 04.
Article de En | MEDLINE | ID: mdl-38296760
ABSTRACT

AIMS:

Because tobacco smoking is a major risk factor of mortality in diabetes and guidelines suggest evaluating smoking behavior among individuals with diabetes and helping smokers quit, we aimed to assess knowledge about the tobacco smoking - diabetes relationship among diabetologists and smoking cessation specialists (SCS).

METHODS:

An online cross sectional survey was conceived by the Working Group on Smoking and Diabetes, France. The questionnaire was tested by the members of the Working Group and deemed to be completed in less than 5 min. Only questions receiving the highest number of approval ratings were kept for the survey. The questionnaire was sent to all members of the French Language Society of Diabetes (Société Francophone du Diabète, SFD), N = 969 and the French Language Society on Tobacco (Société Francophone de Tabacologie, SFT), N = 307. The mailing lists of members were obtained with the previous agreement of the societies' board.

RESULTS:

225 diabetologists and 97 SCS (response rate 23.2% and 31.5%, respectively) completed the questionnaire. Over 90% of the diabetologists reported recording smoking status of their patients. Although diabetologists were aware that smoking increases all-cause mortality of individuals with diabetes, only 29.3% were aware that smoking is a risk factor for type 2 diabetes (76.3% among SCS), for poor glycemic control 32.9% (86.6% among SCS). Significantly less diabetologists (64%) than SCS (76.3%) were aware of smoking being a risk factor for microangiopathy. More diabetologists considered that smoking cessation is more important than optimizing glycemic control among individuals with type 2 (69.3%) than among those with type 1 diabetes (47.1%). Few diabetologists (11.1%) and SCS (14.4%) reported to be trained for smoking cessation among persons with diabetes.

CONCLUSION:

Specific knowledge about the negative tobacco smoking - diabetes association seems to be insufficient among French diabetologists. Diabetologists but also other health care professionals should be trained to help individuals with diabetes who smoke to quit smoking.
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Arrêter de fumer / Diabète de type 2 Type d'étude: Qualitative_research / Risk_factors_studies Limites: Humans Langue: En Journal: Prim Care Diabetes / Prim. care diabetes / Primary care diabetes (Print) Sujet du journal: ENDOCRINOLOGIA Année: 2024 Type de document: Article Pays de publication: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Arrêter de fumer / Diabète de type 2 Type d'étude: Qualitative_research / Risk_factors_studies Limites: Humans Langue: En Journal: Prim Care Diabetes / Prim. care diabetes / Primary care diabetes (Print) Sujet du journal: ENDOCRINOLOGIA Année: 2024 Type de document: Article Pays de publication: Royaume-Uni